Journal of Gastrointestinal & Digestive System
Open Access

Abstract

Inflammatory bowel diseases (IBD) affect mainly young people who may have pregnancy will. Despite many studies and recommendations, patients and gastroenterologists still have bias ideas regarding risks and consequences of pregnancy in IBD patients. This may lead to voluntary infertility or bad observance, whereas a controlled disease and maintenance therapy are key points to minimize the risk of maternal or fetal complications. Except for methotrexate, most IBD medications do not have any side effects on the offspring. Disease flare has to be treated properly without delay and corticosteroids should be the first treatment to propose. Surgery should not be delayed if needed. Patient education and information should be promoted before and during all pregnancy. Here we present a review of the last studies regarding management of pregnancy in IBD according to the last European guidelines.

Biography

Triki Ismail is a Gastroenterologist and specialist in the management of IBD has his hospital and liberal experience to treat inflammatory bowel disease in all of these aspects. As he has done research work in this direction and he is also Member of several associations for patients.